TY  - JOUR
T1  - TReatment of congestive heart failure
AU  - de Denus S, Spinler SA
Y1  - 2002/05/01
N1  - 10.1001/jama.287.17.2209
JO  - JAMA
SP  - 2209
EP  - 2210
VL  - 287
IS  - 17
N2  - 
To the Editor: In their Scientific Review article
about the management of advanced heart failure, Dr Nohria and colleagues1 suggested that angiotensin II receptor blockers
(ARBs) are a reasonable alternative for patients who cannot tolerate angiotensin
converting enzyme (ACE) inhibitors because of severe cough or angioedema.
Although we agree that ARBs, or a combination of hydralazine and a nitrate,
constitute a reasonable alternative in patients experiencing persistent cough
associated with receiving ACE inhibitors, we believe that ARBs in patients
with a history of an ACE inhibitor–associated angioedema should only
be used with extreme caution, if at all.

SN  - 0098-7484
M3  - doi: 10.1001/jama.287.17.2209
UR  - http://dx.doi.org/10.1001/jama.287.17.2209
ER  -